Jadenu and Bronchitis - a phase IV clinical study of FDA data

Summary:

Bronchitis is reported as a side effect among people who take Jadenu (deferasirox), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Exjade, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Bronchitis when taking Jadenu. It is created by eHealthMe based on reports of 4,173 people who have side effects when taking Jadenu from the FDA, and is updated regularly.

What is Jadenu?

Jadenu has active ingredients of deferasirox. eHealthMe is studying from 4,176 Jadenu users. Check the latest studies of Jadenu.

What is Bronchitis?

Bronchitis (inflammation of the mucous membrane in the bronchial tubes) is found to be associated with 2,328 drugs and 2,440 conditions by eHealthMe. Check the latest studies of Bronchitis.

On Jul, 21, 2026

4,173 people reported to have side effects when taking Jadenu.
Among them, 34 people (0.81%) have Bronchitis.

Among these 34 people:

How long have people been on Jadenu when they have Bronchitis? *

What is the gender of people who have Bronchitis when taking Jadenu? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Bronchitis when taking Jadenu? *

What are other drugs people take besides Jadenu? *

What are other side effects people have besides Bronchitis? *

Haemoglobin Decreased: 22 people, 64.71%
Fatigue (feeling of tiredness): 21 people, 61.76%
Constipation: 16 people, 47.06%
Urinary Tract Infection: 15 people, 44.12%
Diarrhea: 14 people, 41.18%
Indigestion: 13 people, 38.24%
Abdominal Pain Upper: 13 people, 38.24%
Back Pain: 12 people, 35.29%
Blood Creatinine Increased: 10 people, 29.41%
Blood Iron Increased: 9 people, 26.47%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 17 people, 50.00%
Iron Overload: 16 people, 47.06%
Primary Myelofibrosis (primary disorder of the bone marrow): 9 people, 26.47%
Urinary Tract Infection: 6 people, 17.65%
Colitis (inflammation of colon): 6 people, 17.65%
Brain Neoplasm (tumour of brain): 6 people, 17.65%
Blood Pressure Abnormal: 6 people, 17.65%
Blood Potassium Abnormal: 6 people, 17.65%
Haemochromatosis (body to absorb more iron than usual from food): 2 people, 5.88%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Jadenu and have Bronchitis?

- Check whether Bronchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jadenu:

Jadenu (4,176 reports)

Bronchitis treatments and more:

Bronchitis (118,921 reports)

Browse all side effects of Jadenu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchitis:

Bronchitis (2,328 drugs)

Browse all the conditions that are associated with Bronchitis:

Bronchitis (2,440 conditions)

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on deferasirox (the active ingredients of Jadenu) and Jadenu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.